‘Heart-on-a-Chip’ For Safer Cancer Treatment
Cedars-SinaiChemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety.
Chemotherapy can be toxic to heart cells. To help protect the hearts of cancer patients, Cedars-Sinai investigators have created a three-dimensional “heart-on-a-chip” to evaluate drug safety.
Thomas M. Priselac, whose leadership over the last 30 years as Cedars-Sinai’s president and CEO significantly expanded the scope and quality of its clinical, educational, research and community benefit programs, has announced his plans to retire.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for January 2024.
Like the rest of the country, Los Angeles County has experienced a dramatic upswing in overdoses from fentanyl, an opiate that is 100 times stronger than heroin.
Cardiologists and cardiac and vascular surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews throughout February to discuss heart-related topics, including the latest advances in research and patient care.
Cedars-Sinai and Space Tango are planning their third launch of pilot-scale systems for the automated in-space production of stem cells to the International Space Station.
Interventions to address the risks older people can face taking multiple medications need significant improvement, according to a study by Cedars-Sinai investigators.
Cardiothoracic surgeons and investigators from the Smidt Heart Institute at Cedars-Sinai will lead sessions featuring a range of heart procedures at the 60th Annual Meeting of The Society of Thoracic Surgeons (STS), Jan. 27-29, 2024, in San Antonio, Texas.
Investigators from the Smidt Heart Institute at Cedars-Sinai and colleagues found that women with fatty liver disease related to alcohol consumption have almost twice the risk of dying within a certain time period than men with the same condition.
You may not know Carol Barr, but in the future, she could save your life. Barr’s death at 39 from sudden cardiac arrest was caused by mitral valve prolapse—a heart valve defect that can affect the heart’s ability to pump blood. It can, in some cases, lead to death.
A team of experts from Cedars-Sinai International will participate in Arab Health, Jan. 29-Feb. 1, in Dubai, United Arab Emirates, underscoring Cedars-Sinai’s commitment to growing its worldwide presence by supporting innovative, advanced collaborative medical care for millions of patients around the globe.
The View Hospital in affiliation with Cedars-Sinai is proud to announce that it will host the inaugural "Innovations in Orthopedics Symposium" on Jan. 27 at the Equestrian Club in Doha, Qatar.
Cedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival.
A roundup of 2023 medical discoveries and innovations at Cedars-Sinai Cancer.
Heart rhythm expert Sumeet Chugh, MD, associate director of the Smidt Heart Institute at Cedars-Sinai, is the recipient of this year’s American College of Cardiology (ACC) Distinguished Scientist Award-Clinical Domain.
New research by investigators from the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai shows that behavioral activation therapy is as effective as antidepressant medications in treating symptoms of depression in patients with heart failure.
Yvette Bordelon, MD, PhD, who specializes in some of the most difficult-to-treat movement disorders, has joined the Movement Disorders Program in the Department of Neurology at Cedars-Sinai. She will work on clinical trials and treat patients with Parkinson’s disease, Huntington’s disease and other movement disorders, which currently have no cure.
One of the Smidt Heart Institute’s leading experts in artificial intelligence, David Ouyang, MD, has been named a deputy editor of NEJM AI—a newly established, peer-reviewed journal from the publishers of the highly respected, New England Journal of Medicine.
Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the peer-reviewed Journal of the American Geriatrics Society, is designed to help medical staff tailor care to best serve these patients.
Women who received standard recommended immunizations during their pregnancy were more likely to accept the COVID-19 vaccine, according to new research from Cedars-Sinai. Investigators also identified disparities in vaccination linked to race and insurance status.
The choices that Bruce Gold faced last December to resolve debilitating symptoms from a severely enlarged prostate were to keep using a catheter or have an invasive surgery with unreliable results and a high risk of complications and lingering side effects.
Cedars-Sinai Cancer investigators have analyzed the cells within triple-negative breast cancer tumors before and after radiation therapy with immunotherapy, identifying three patient groups with different responses to the treatment.
As the new year kicks into full swing, so has a trio of respiratory viruses, creating a so-called tripledemic.
A new research study from the Smidt Heart Institute at Cedars-Sinai aimed to understand the possible connection between COVID-19 vaccination and a difficult-to-diagnose heart condition called postural orthostatic tachycardia syndrome, or POTS.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai for December 2023.
Wars abroad. Struggles at home, including record-setting inflation and political polarization. Although the holiday season can trigger a range of emotions, this year may feel especially challenging.
The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the evaluation and long-term monitoring of patients with enlarged aortas, or aortic aneurysms, for whom surgery may not be necessary.
New research from the Smidt Heart Institute at Cedars-Sinai found that women who developed signs of elevated blood pressure during pregnancy were more likely to have residual evidence of abnormal heart structure and function up to a decade after the pregnancy.
Cedars-Sinai Cancer investigators have discovered a new way to predict whether a cancer of the immune system will recur in patients treated with a bone marrow transplant.
Cedars-Sinai Cancer is part of an unconventional consortium dedicated to fighting cancer through the integration of diverse scientific disciplines.
In the summer of 2022, an overwhelmed Jon Anderson was nervously preparing for a big moment—having robotic coronary artery bypass surgery. Just over a year later, in the fall of 2023, Anderson was staring down another major life event.
An artificial intelligence (AI) tool developed by investigators at the Smidt Heart Institute at Cedars-Sinai and colleagues at two other institutions accurately predicted how patients would fare after surgeries and procedures.
New research from Cedars-Sinai’s Comprehensive Transplant Center found that a monoclonal antibody treatment reduced the risk of COVID-19 in a large group of solid organ transplant patients who were administered the drug as a preventive measure against the disease.
The Smidt Heart Institute at Cedars-Sinai has expanded its popular Virtual Second Opinion Program to women living with or at risk of developing heart disease, the nation’s leading cause of death in women.
The winter holiday season is a time to slow down, relax, and enjoy time with family and friends. That is, unless you’re a trauma surgeon.
Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects middle-aged women, according to a study led by Cedars-Sinai investigators.
Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.
A new Cedars-Sinai study might have cracked the mystery surrounding the cause of a specific type of back pain.
By the time cancer survivor Sydnee Meth found an effective treatment for the pain she had coped with for years, her right arm was so swollen and heavy that she could not lift it past her shoulder.
The holidays can be the best of times or the worst of times. High-energy celebrations, the emphasis on good tidings of joy, and reunions with families and friends can bring happiness and comfort, but they can have the opposite effect on people feeling isolated and alone, especially older adults.
This holiday season, Valance Sams, Sr. hopes to finish the most important thank-you note he’s ever written—one he’s been pondering for months. It’s been challenging to get all that he wants to say down on paper, in just the right way. Most days, a flood of emotions gets in his way.
With the holiday season underway, and families and friends gathering to celebrate, a leading Cedars-Sinai Guerin Children’s pediatrician has one word of advice for parents: Vaccinate.
David Epstein, MD, a pediatrician who has dedicated his career to caring for very ill children, has been selected as the new director of Pediatric and Congenital Cardiac Intensive Care at Cedars-Sinai Guerin Children’s.
Hailing from Park City, Utah, Riley Mulholland enjoyed an upbringing steeped in the vibrant active outdoor sports culture of his hometown. From an early age, Mulholland took to the slopes, played football and lacrosse; he was the definition of a multisport athlete.
A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.
Cedars-Sinai investigators found no established link between the use of assisted reproductive technologies and potential problems in DNA methylation that might impact genetic expression or embryonic development.
This Thanksgiving marks a little more than 25 years since Christine Galan became the first person in the Western U.S. to have a combined organ transplant (heart and liver), and nearly five years since she returned to Cedars-Sinai for another organ transplant—this time, a kidney.
The Chuck Lorre Family Foundation is doubling down on its commitment to supporting healthcare opportunities for young people, through Cedars-Sinai’s Youth Employment and Development (YED) Health Careers Academy.
Investigators from the Barbra Streisand Women’s Heart Center in the Smidt Heart Institute at Cedars-Sinai have found that among a cohort of women with obstructive coronary artery disease treated at academic medical centers, racial and ethnic disparities did not impact their long-term outcomes.
How does anyone know for sure that they were born the wrong gender? What should parents do when their child tells them? And how do transgender patients prepare for gender-affirming surgery, if that’s what they decide to do?